Global Plasma Fractionation Market Overview: 2025-2030

Base Year: 2024

Historical Years:  2020–23

Forecast Years: 2025-2030

The Global Plasma Fractionation Market size was valued at around USD 31.18 billion in 2024 and is projected to reach USD 42.39 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.51% during the forecast period, i.e., 2025-30.

Our Latest Reports Now Include In-Depth Supply Chain Ecosystem Analysis, Enabling Businesses to Navigate Tariff Challenges with Greater Agility Get Sample Report – https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

Global Plasma Fractionation Market Dynamics: 2025-2030

Global Plasma Fractionation Market Driver:

Escalating Geriatric Population Driving the Demand for Plasma-derived Therapies – Globally, the surging geriatric population has resulted in a substantial boost in the incidences of diseases like immunodeficiency, neurological disorders, etc., which require plasma-derived therapies for treatment. The increment in the geriatric population has been attributed to the increasing life expectancy of the elderly population in various countries like China, Japan, etc., as a result of their improved healthcare infrastructure. Consequently, as the number of geriatric patients has been increasing, there has been an enhanced demand for plasma-derived therapeutic products, presenting a strong market situation for plasma fractionation manufacturers, particularly immunoglobulins and coagulation factors during historical years.

Further, in response to this growing demand on a global scale, companies specializing in plasma fractionation have proactively started investing in expanding their plasma therapy manufacturing facilities. Such strategic initiatives by companies across the world position them to better address the increasing need for improved treatment, ultimately contributing to positive growth of the Plasma Fractionation Market.

Browse Full Report with Detail Analysis – https://www.marknteladvisors.com/research-library/plasma-fractionation-market.html

Global Plasma Fractionation Market (2025-30): Segmentation Outlook

The market report has segmented the market into the following categories:

By Product

-Immunoglobulin- Market Size Forecast 2020-2030, (USD Million)

--Intravenous Immunoglobulin- Market Size Forecast 2020-2030, (USD Million)

--Subcutaneous Immunoglobulin- Market Size Forecast 2020-2030, (USD Million)

--Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size Forecast 2020-2030, (USD Million)

-Coagulation Factors- Market Size Forecast 2020-2030, (USD Million)

--Factor VIII- Market Size Forecast 2020-2030, (USD Million)

--Factor IX- Market Size Forecast 2020-2030, (USD Million)

--Von Willebrand Factor (vWF) - Market Size Forecast 2020-2030, (USD Million)

--Prothrombin Complex Concentrates- Market Size Forecast 2020-2030, (USD Million)

--Fibrinogen Concentrates- Market Size Forecast 2020-2030, (USD Million)

--Factor XIII- Market Size Forecast 2020-2030, (USD Million)

--Others (Factor VIIa, Factor XI, etc.)- Market Size Forecast 2020-2030, (USD Million)

-Albumin- Market Size Forecast 2020-2030, (USD Million)

-Protease Inhibitor- Market Size Forecast 2020-2030, (USD Million)

-Others (Plasminogen, Antithrombin III, etc.) - Market Size Forecast 2020-2030, (USD Million)

By Application

-Neurology- Market Size Forecast 2020-2030, (USD Million)

-Immunology- Market Size Forecast 2020-2030, (USD Million)

-Hematology- Market Size Forecast 2020-2030, (USD Million)

-Critical Care- Market Size Forecast 2020-2030, (USD Million)

-Pulmonology- Market Size Forecast 2020-2030, (USD Million)

-Rheumatology- Market Size Forecast 2020-2030, (USD Million)

-Others (Oncology, Pediatrics, etc.) - Market Size Forecast 2020-2030, (USD Million)

The Neurology segment held the major share of the Plasma Fractionation Market,

By End User

-Hospitals - Market Size Forecast 2020-2030, (USD Million)

-Specialty Clinics- Market Size Forecast 2020-2030, (USD Million)

-Research Facilities - Market Size Forecast 2020-2030, (USD Million)

By Region

-North America

-South America

-Europe

-The Middle East Africa

-Asia-Pacific.

North America emerged as the dominant player in the Global Plasma Fractionation Market.

Note - If there are any particular details you need that are not currently included in the report, we will be happy to provide them as part of our customization services.

Top Companies Operating in the Global Plasma Fractionation Market:

-Biotest A.G.

-Octapharma A.G.

-Adma Biologics

-Aegros

-CSL Limited

-Grifols S.A.

-Kedrion Biopharma Inc.

-Bio Products Laboratory Ltd                                 

-Takeda Pharmaceuticals

-Emergent Bio solutions

-Intas Pharmaceutical

-Plasma Gen Biosciences

-S K Plasma.

 Industry Recent Development:

• In 2023, Octapharma AG received expanded FDA approval for its plasma-based product, wilate, for routine prophylaxis to reduce bleeding episodes in adults and children aged six and older.
• In 2023, Grifols, S.A. obtained FDA approval for a new immunoglobulin purification and filling facility in North Carolina, boosting its production capacity by an additional 16 million grams of plasma therapy annually.
• In 2023: Bio Products Laboratory (BPL) announced the establishment of a strategic partnership with CSI Pharmacy to offer distribution rights to BPL’s immune globulin product Gammaplex.

Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel, and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address

About Us –

We are a leading market research company, consulting, data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial varied client base, including multinational corporations, financial institutions, governments, individuals, among others.

Our specialization in niche industries emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing forecasting, trend analysis, among others, for 15 diverse industrial verticals.

Contact Us –

Email: sales@marknteladvisors.com

Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Address Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India